Biodexa Pharmaceuticals (BDRX) Depreciation and Depletion (2019 - 2021)
Biodexa Pharmaceuticals (BDRX) reported Depreciation and Depletion of $86148.1 for Q3 2021, down 23.13% on a YoY basis from $112076.0 in Q3 2020, and down 26.7% sequentially from $117520.1 in Q4 2020.
Biodexa Pharmaceuticals (BDRX) Depreciation and Depletion (2019 - 2021) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 3 years of Depreciation and Depletion data on file, last reported at $86148.1 in Q3 2021.
- For the quarter ending Q3 2021, Depreciation and Depletion fell 23.13% year-over-year to $86148.1; the trailing twelve-month figure through Sep 2021 stood at $473888.3 (changed N/A YoY), and the FY2025 full-year result was $179317.4, up 3.49% from the prior year.
- Depreciation and Depletion fell to $86148.1 in Q3 2021, from $117520.1 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $158144.2 in Q4 2019 to a low of $86148.1 in Q3 2021.
- A 3-year average of $118472.1 and a median of $114798.0 in 2020 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion declined 25.69% in 2020 and decreased 23.13% in 2021, its largest moves.
- Tracing BDRX's Depreciation and Depletion over 3 years: stood at $158144.2 in 2019, then decreased by 25.69% to $117520.1 in 2020, then fell by 26.7% to $86148.1 in 2021.
- Business Quant data shows BDRX's Depreciation and Depletion at $86148.1 in Q3 2021, $117520.1 in Q4 2020, and $112076.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Biodexa Pharmaceuticals | 18.43 Bn | 18.43 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 17, 2021 | 86,148.06 |
| Sep 17, 2021 | 86,148.06 |
| Dec 31, 2020 | 117,520.14 |
| Dec 31, 2020 | 117,520.14 |
| Sep 10, 2020 | 112,075.95 |
| Sep 10, 2020 | 112,075.95 |
| Dec 31, 2019 | 158,144.16 |
| Dec 31, 2019 | 158,144.16 |